Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Analysis of Asymetric Dimethylarginine and Homocysteine in Patients with Chronic Kidney Disease

The Indonesian Biomedical Journal · Vol. 1 No. 2 (2009) · hlm. 64–64

DOI
10.18585/inabj.v1i2.96
ISSN
2085-3297, 2355-9179
Terbit
2009-08-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of nitric oxide synthase (NOS). ADMA reduces NO synthesis when its concentration elevates. ADMA is a novel risk factor for cardiovascular disease. Plasma ADMA accumulates in patients with endstage renal disease, due to reduced renal clearance. Hyperhomocysteinemia is often found in patients with chronic kidney disease (CKD). Homocysteine may cause ADMA to accumulate; however, the mechanism by which ADMA level elevates in hyperhomocysteinemia is still unclear. Objective of this study was to analyze the concentrations of homocysteine and ADMA and to assess the correlation between homocysteine and ADMA concentrations with the severity of chronic kidney disease.METHODS: This was a cross-sectional study on 75 patients with CKD, comprising men and women aged 40-70 years. Assessments were done on the concentrations of creatinine, homocysteine, ADMA, fasting blood glucose, cholesterol HDL and triglyceride.RESULTS: In later stage of CKD there was significantly higher tHcy concentration as compared with the earlier stage of CKD (p=0.0000). In CKD stage 2 to 4 there was a tendency for ADMA concentration to increase to a significant average (p=0.210), but ADMA concentration was lower at stage 5. There was increased ADMA along with increased tHcy concentration of around 20μ mol/L, and this then decreased. The inverse correlation between tHcy and ADMA concentrations started to appear in CKD stage 4, but this correlation was statistically insignificant (r2 =0.19; p=0.499).CONCLUSIONS: This study showed there was a correlation between homocysteine and ADMA concentrations in patients with CKD stage 2 to 5, although statistically not significant.KEYWORDS: Asymetric Dimethylarginine, Homocysteine, Chronic Kidney Disease

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 106 tautan kepenulisan bersama · 25 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • Udayana University
  • Universitas Trisakti
  • Universitas Airlangga
  • University of Indonesia
  • Sam Ratulangi University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University6
Anwar SantosoUdayana University4
Uleng BahrunHasanuddin University3
Ferry SandraUniversitas Trisakti3
Trilis YuliantiHasanuddin University3
Gatot Susilo LawrenceHasanuddin University2
Meiriza DjohariHasanuddin University2
Antonia Anna LukitoHasanuddin University2
Ilhamjaya PatellongiHasanuddin University2
Marsetio DonosepoetroUniversitas Airlangga2
Yati SumiyatiHasanuddin University2
Maria Evi NoviantiAfiliasi tidak diketahui2
Diana SitohangHasanuddin University1
Rachmawati AMHasanuddin University1
Darmawati E RAfiliasi tidak diketahui1
Liong Boy KurniawanHasanuddin University1
Fitriani MangarengiHasanuddin University1
Erizal SugionoHasanuddin University1
Ampi RetnowarnadiAfiliasi tidak diketahui1
Siti Boedina KresnoUniversity of Indonesia1
Maisuri T. ChalidHasanuddin University1
John J. E. WantaniaHasanuddin University1
Karel PandelakiSam Ratulangi University1
Adriana TodingranteHasanuddin University1
Johnson WijayaAfiliasi tidak diketahui1
Irawan YusufHasanuddin University1
Waode NurfinaHasanuddin University1
Lies GantiniHasanuddin University1
Dedeh YuniartyAfiliasi tidak diketahui1
Mulyana MulyanaHasanuddin University1
Dewi MuliatyAfiliasi tidak diketahui1
Wiwik RositawatiHasanuddin University1
Yuliana SambaraHasanuddin University1
Burhanuddin BaharHasanuddin University1
Indriyanti Rafi SukmawatiHasanuddin University1
Lia MelianiHasanuddin University1
Allen WidyasantoHasanuddin University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">The Analysis of Asymetric Dimethylarginine and Homocysteine in Patients with Chronic Kidney Disease</dc:title><dc:creator>Tetty Hendrawati</dc:creator><dc:creator>Syakib Bakri</dc:creator><dc:creator>Mansyur Arif</dc:creator><dc:subject>asymmetric dimethylarginine</dc:subject><dc:subject>homocysteine</dc:subject><dc:subject>chronic kidney disease</dc:subject><dc:subject>hyperhomocysteinemia</dc:subject><dc:subject>nitric oxide synthase inhibition</dc:subject><dc:subject>cardiovascular risk factors</dc:subject><dc:subject>CKD staging</dc:subject><dc:subject>plasma biomarkers</dc:subject><dc:subject>end-stage renal disease</dc:subject><dc:description xml:lang="en">BACKGROUND: Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of nitric oxide synthase (NOS). ADMA reduces NO synthesis when its concentration elevates. ADMA is a novel risk factor for cardiovascular disease. Plasma ADMA accumulates in patients with endstage renal disease, due to reduced renal clearance. Hyperhomocysteinemia is often found in patients with chronic kidney disease (CKD). Homocysteine may cause ADMA to accumulate; however, the mechanism by which ADMA level elevates in hyperhomocysteinemia is still unclear. Objective of this study was to analyze the concentrations of homocysteine and ADMA and to assess the correlation between homocysteine and ADMA concentrations with the severity of chronic kidney disease.METHODS: This was a cross-sectional study on 75 patients with CKD, comprising men and women aged 40-70 years. Assessments were done on the concentrations of creatinine, homocysteine, ADMA, fasting blood glucose, cholesterol HDL and triglyceride.RESULTS: In later stage of CKD there was significantly higher tHcy concentration as compared with the earlier stage of CKD (p=0.0000). In CKD stage 2 to 4 there was a tendency for ADMA concentration to increase to a significant average (p=0.210), but ADMA concentration was lower at stage 5. There was increased ADMA along with increased tHcy concentration of around 20μ mol/L, and this then decreased. The inverse correlation between tHcy and ADMA concentrations started to appear in CKD stage 4, but this correlation was statistically insignificant (r2 =0.19; p=0.499).CONCLUSIONS: This study showed there was a correlation between homocysteine and ADMA concentrations in patients with CKD stage 2 to 5, although statistically not significant.KEYWORDS: Asymetric Dimethylarginine, Homocysteine, Chronic Kidney Disease</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2009-08-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v1i2.96</dc:identifier><dc:identifier>10.18585/inabj.v1i2.96</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 1 No 2 (2009); 64-64</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/96/109</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>